The U.S. International Trade Commission (ITC) has issued an order that could potentially bar Apple from importing its Apple Watches. The decision comes after the ITC found that the devices violate the patent rights of medical technology company Masimo.
Specifically, Apple's use of light-based technology for reading blood-oxygen levels infringes on Masimo's rights, according to Bloomberg.
Presidential Review and Possible Appeals Await the Decision
Reuters reported that while the ITC ruling will not have an immediate effect, it now faces review by President Joe Biden's administration. The administration will have 60 days to determine whether to veto the import ban based on policy concerns before it goes into effect.
It is worth noting that presidents rarely veto bans in these circumstances. Additionally, Apple can appeal the ban to the U.S. Court of Appeals for the Federal Circuit after the review period ends.
Masimo Chief Executive Officer Joe Kiani has expressed satisfaction with the ruling, stating that it "sends a powerful message that even the world's largest company is not above the law."
The ITC decision, however, did not specify which models of Apple Watches would be affected by the ban. Masimo's original complaint mentioned that the 2020 Apple Watch Series 6, which introduced blood-oxygen monitoring capabilities, infringed on its patents.
Intellectual Property Fight Between Apple and Masimo
The dispute between Apple and Masimo spans several jurisdictions and began with Masimo accusing Apple of stealing its technology and incorporating it into multiple Apple Watch models. In May, a jury trial on Masimo's allegations in a California federal court ended with a mistrial.
In addition to the ITC case, Apple has separately sued Masimo for patent infringement in federal court in Delaware. Apple claims that Masimo's legal actions are a tactical move to clear the path for its competing smartwatch.
Apple is also involved in a patent dispute with medical technology company AliveCor, which has led to an ITC-issued ban on Apple Watch imports. However, the ban is currently on hold during related proceedings concerning the validity of AliveCor's patents.
According to a company report, Apple's wearables, home, and accessory business, including the Apple Watch, AirPods earbuds, and other products, produced an impressive revenue of $8.28 billion in the third quarter of 2023.
Photo: Sophia Stark/Unsplash


HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Australia Enforces World-First Social Media Age Limit as Global Regulation Looms
Trump Signs Executive Order to Establish National AI Regulation Standard
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
Microsoft Unveils Massive Global AI Investments, Prioritizing India’s Rapidly Growing Digital Market
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
EssilorLuxottica Bets on AI-Powered Smart Glasses as Competition Intensifies
SK Hynix Considers U.S. ADR Listing to Boost Shareholder Value Amid Rising AI Chip Demand
Apple App Store Injunction Largely Upheld as Appeals Court Rules on Epic Games Case
Robinhood Expands Sports Event Contracts With Player Performance Wagers
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Moore Threads Stock Slides After Risk Warning Despite 600% Surge Since IPO
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 



